GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infection.
Foo CX, Bartlett S, Chew KY, Ngo MD, Bielefeldt-Ohmann H, Arachchige BJ, Matthews B, Reed S, Wang R, Smith C, Sweet MJ, Burr L, Bisht K, Shatunova S, Sinclair JE, Parry R, Yang Y, Lévesque JP, Khromykh A, Rosenkilde MM, Short KR, Ronacher K.
Foo CX, et al. Among authors: ronacher k.
Eur Respir J. 2023 Mar 9;61(3):2201306. doi: 10.1183/13993003.01306-2022. Print 2023 Mar.
Eur Respir J. 2023.
PMID: 36396144
Free PMC article.